William Wade's most recent trade in Sierra Bancorp was a trade of 13,990 Common Stock done . Disclosure was reported to the exchange on Nov. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sierra Bancorp | William Wade | EVP/Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 13,990 | 13,990 (0%) | 0% | 0 | Common Stock | |
| MaxCyte Inc | William Wade Brooke | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 13 Aug 2025 | 50,000 | 150,879 | - | 1.3 | 64,500 | Common Stock |
| EchoStar Corp (Class A) | William Wade D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 5,000 | 0 | - | - | Non-Employee Director Stock Options | |
| EchoStar Corp (Class A) | Wade William D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.28 per share. | 01 Jul 2025 | 5,000 | 5,134 (0%) | 0% | 27.3 | 136,400 | Class A Common Stock |
| EchoStar Corp (Class A) | Wade William D. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.36 per share. | 01 Jul 2025 | 4,810 | 324 (0%) | 0% | 28.4 | 136,412 | Class A Common Stock |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 50,790 | 50,790 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 29,210 | 100,879 | - | 0 | Common Stock | |
| EchoStar Corp (Class A) | William D. Wade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 5,000 | 5,000 | - | - | Non-Employee Director Stock Option | |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 40,701 | 40,701 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 21,367 | 71,669 | - | 0 | Common Stock | |
| EchoStar Corp (Class A) | William D. Wade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 10,000 | 10,000 | - | - | Non-Employee Director Stock Option | |
| EchoStar Corp (Class A) | D. Wade William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 134 | 134 (0%) | 0% | - | Class A Common Stock | |
| EchoStar Corp (Class A) | William D. Wade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 5,000 | 5,000 | - | - | Non-Employee Director Stock Option (right to buy) | |
| EchoStar Corp (Class A) | William D. Wade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,000 | 5,000 | - | - | Non-Employee Director Stock Option | |
| EchoStar Corp (Class A) | William D. Wade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 5,000 | 5,000 | - | - | Non-Employee Director Stock Option |